€150.00
€150.00
Emtricitabine / Tenofovirdisoproxil is a combination antiviral medicine used to treat HIV infection and to reduce the risk of acquiring HIV when used as PrEP. It helps suppress viral replication and lower viral load when taken as prescribed.
Emtricitabine / Tenofovirdisoproxil is a combination antiviral medicine used to treat HIV infection and to reduce the risk of acquiring HIV when used as PrEP. It helps suppress viral replication and lower viral load when taken as prescribed.
| Medication Strength | 200 mg/245 mg |
|---|---|
| Amount | 30, 60, 90 |
This medicine combines emtricitabine and tenofovir disoproxil, both of which block the HIV reverse transcriptase enzyme required for viral replication.
For HIV treatment, it must always be used in combination with other antiretroviral medicines.
Emtricitabine / Tenofovirdisoproxil is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, and for HIV pre-exposure prophylaxis (PrEP) in individuals at high risk of HIV infection, as determined by a healthcare professional.
What is Emtricitabine / Tenofovirdisoproxil used for?
It is used to treat HIV infection (as part of combination therapy) and to reduce the risk of HIV infection when used as PrEP.
Does this medicine cure HIV?
No. It does not cure HIV, but it helps control the virus and protect the immune system.
How effective is PrEP with this medicine?
When taken consistently as prescribed, it significantly reduces the risk of acquiring HIV.
Do I still need to use condoms?
Yes. Condoms help protect against other sexually transmitted infections and provide additional HIV protection.
Can I miss a dose?
Missing doses reduces effectiveness. Take it as prescribed and speak to your healthcare provider if adherence is difficult.
Is regular testing required?
Yes. Regular HIV testing and medical monitoring are required, especially when used for PrEP.